These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35661128)

  • 41. Remote electrical neuromodulation for acute treatment of migraine in adolescents.
    Hershey AD; Lin T; Gruper Y; Harris D; Ironi A; Berk T; Szperka CL; Berenson F
    Headache; 2021 Feb; 61(2):310-317. PubMed ID: 33349920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An update on migraine: Current and new treatment options.
    Hervias T
    JAAPA; 2024 May; 37(5):1-7. PubMed ID: 38662902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
    Diener HC; Goadsby PJ; Ashina M; Al-Karagholi MA; Sinclair A; Mitsikostas D; Magis D; Pozo-Rosich P; Irimia Sieira P; Làinez MJ; Gaul C; Silver N; Hoffmann J; Marin J; Liebler E; Ferrari MD
    Cephalalgia; 2019 Oct; 39(12):1475-1487. PubMed ID: 31522546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occipital Nerve Stimulation: An Alternative Treatment of Chronic Migraine.
    Maxey BS; Pruitt JW; Deville A; Montgomery C; Kaye AD; Urits I
    Curr Pain Headache Rep; 2022 Apr; 26(4):337-346. PubMed ID: 35286589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial.
    Ornello R; Rosignoli C; Caponnetto V; Pistoia F; Ferrara M; D'Atri A; Sacco S
    Front Neurol; 2022; 13():890364. PubMed ID: 35620782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study.
    Goadsby PJ; de Coo IF; Silver N; Tyagi A; Ahmed F; Gaul C; Jensen RH; Diener HC; Solbach K; Straube A; Liebler E; Marin JC; Ferrari MD;
    Cephalalgia; 2018 Apr; 38(5):959-969. PubMed ID: 29231763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Randomized, Sham-Controlled Trial of Bilateral Greater Occipital Nerve Blocks With Bupivacaine for Acute Migraine Patients Refractory to Standard Emergency Department Treatment With Metoclopramide.
    Friedman BW; Mohamed S; Robbins MS; Irizarry E; Tarsia V; Pearlman S; John Gallagher E
    Headache; 2018 Oct; 58(9):1427-1434. PubMed ID: 30144034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials.
    Clark O; Mahjoub A; Osman N; Surmava AM; Jan S; Lagman-Bartolome AM
    Neurol Sci; 2022 Jan; 43(1):153-165. PubMed ID: 34698941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of High-Definition Transcranial Direct Current Stimulation on Headache Severity and Central µ-Opioid Receptor Availability in Episodic Migraine.
    DaSilva AF; Kim DJ; Lim M; Nascimento TD; Scott PJH; Smith YR; Koeppe RA; Zubieta JK; Kaciroti N
    J Pain Res; 2023; 16():2509-2523. PubMed ID: 37497372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurostimulation for the Treatment of Chronic Head and Facial Pain: A Literature Review.
    Antony AB; Mazzola AJ; Dhaliwal GS; Hunter CW
    Pain Physician; 2019 Sep; 22(5):447-477. PubMed ID: 31561646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.
    Cady RK; Saper J; Dexter K; Cady RJ; Manley HR
    Headache; 2015 Apr; 55(4):529-42. PubMed ID: 25828648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study.
    Kinfe TM; Pintea B; Muhammad S; Zaremba S; Roeske S; Simon BJ; Vatter H
    J Headache Pain; 2015; 16():101. PubMed ID: 26631234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peripheral Neuromodulation for the Management of Headache.
    Urits I; Schwartz R; Smoots D; Koop L; Veeravelli S; Orhurhu V; Cornett EM; Manchikanti L; Kaye AD; Imani F; Varrassi G; Viswanath O
    Anesth Pain Med; 2020 Dec; 10(6):e110515. PubMed ID: 34150578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasound-guided greater occipital nerve block: an efficient technique in chronic refractory migraine without aura?
    Palamar D; Uluduz D; Saip S; Erden G; Unalan H; Akarirmak U
    Pain Physician; 2015; 18(2):153-62. PubMed ID: 25794201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
    Law S; Derry S; Moore RA
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD008541. PubMed ID: 27096438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ibuprofen with or without an antiemetic for acute migraine headaches in adults.
    Rabbie R; Derry S; Moore RA
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008039. PubMed ID: 23633348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine.
    Cady R; Saper J; Dexter K; Manley HR
    Headache; 2015 Jan; 55(1):101-16. PubMed ID: 25338927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study.
    McAllister P; Winner PK; Ailani J; Buse DC; Lipton RB; Chakhava G; Josiassen MK; Lindsten A; Mehta L; Ettrup A; Cady R
    J Headache Pain; 2022 Feb; 23(1):22. PubMed ID: 35130832
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.